Investmentaktiengesellschaft Fuer Langfristige Investoren TGV’s BioNTech BNTX Stock Holding History

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,000	Closed	-$1.58M	–	1
2024 Q4	$1.58M	Hold	14,000	–	–	0.12%	20
2024 Q3	$1.66M	Sell	14,000 -6,500	-32%	-$598K	0.12%	20
2024 Q2	$1.65M	Buy	20,500 +6,000	+41%	+$548K	0.1%	18
2024 Q1	$1.34M	Hold	14,500	–	–	0.09%	19
2023 Q4	$1.53M	Buy	14,500 +3,000	+26%	+$302K	0.11%	19
2023 Q3	$1.25M	Buy	11,500 +500	+5%	+$55.3K	0.1%	18
2023 Q2	$1.19M	Buy	11,000 +8,000	+267%	+$900K	0.1%	18
2023 Q1	$374K	Buy	+3,000	New	+$412K	0.04%	20

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's BNTX Position: Q1 2025 in Review

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 14,000 shares — an estimated $1.58M sold.

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV first reported a position in BNTX in Q1 2023 and held it in 8 quarters. The position peaked at $1.66M in Q3 2024. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
Investmentaktiengesellschaft Fuer Langfristige Investoren TGV sold 14,000 BioNTech shares in Q1 2025, an estimated $1.58M.
Investmentaktiengesellschaft Fuer Langfristige Investoren TGV first reported a position in BioNTech in Q1 2023 and held it in 8 quarters.
Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's BioNTech position peaked at $1.66M in Q3 2024.
280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's 13F filing for Q1 2025.